Phase 2 Open Label Trial of Delgocitinib 20 mg/g Cream in Subjects With Frontal Fibrosing Alopecia (FFA)

This research study is a Phase II clinical trial. Phase II clinical trials test the safety and effectiveness of an investigational study drug to learn whether the delgocitinib 20 mg/g cream works in treating a specific disease. "Investigational" means that the delgocitinib 20 mg/g cream is being studied.

NCT Number	NCT07671157
Lead Sponsor	Maryanne Makredes Senna
Conditions	Frontal Fibrosing Alopecia
Enrollment	30 participants
Start Date	2026-09-10
Primary Completion	2027-10-10 (estimated)
Study Completion	2027-10-10 (estimated)
Updated on ClinicalTrials.gov	2026-06-26